COVID-19 Research and Innovation
Dr. James Crowe Jr. receives SEC Faculty Achievement Award
Apr. 8, 2021—Dr. James E. Crowe Jr., a physician-scientist on the front lines of global research to eliminate human susceptibility to COVID-19 and other illnesses, is Vanderbilt University’s winner of the 2021 Southeastern Conference Faculty Achievement Award.
Coronavirus experts discuss importance of research investments, lessons learned from COVID-19 at Chancellor’s Lecture Series
Mar. 24, 2021—Vanderbilt’s role in shaping each step of the medical response to the COVID-19 pandemic began three decades ago and is grounded in the determination of a small group of scientists to understand coronaviruses. The research, and the faculty and alumni who helped lead it, was the topic of the March 23 Chancellor’s Lecture Series virtual event, “Vanderbilt in the Vanguard: The Decades-Long Journey to a Coronavirus Vaccine.”
Shot in the Arm: Groundbreaking COVID-19 vaccine research by alumnus Dr. Barney Graham began at Vanderbilt decades ago
Mar. 17, 2021—The remarkable success of the COVID-19 vaccines began in a Vanderbilt lab decades ago, with the groundbreaking research of alumnus Dr. Barney Graham.
‘Vanderbilt in the Vanguard’ panel to focus on university’s role in vaccine development
Mar. 15, 2021—Vanderbilt scientists on the front lines of COVID-19 research will share their insights on the pandemic and subsequent vaccine development during a Chancellor’s Lecture Series event on Tuesday, March 23, at 5 p.m. CT, hosted by Chancellor Daniel Diermeier.
Despite limitations of pandemic, research continues at Peabody, College of Arts and Science
Mar. 3, 2021—During the Research Ramp-up process, more than 3,000 Vanderbilt research personnel have returned to in-person research activities, while many others have continued remotely through perseverance and ingenuity. The efforts of Peabody College's James Booth and the College of Arts and Science's Katherine Friedman are highlighted.
Economics’ McGee Public Policy Lecture to discuss ‘The Macroeconomic Policy Response to the Pandemic’ March 9
Mar. 3, 2021—Christina D. Romer, the Class of 1957-Garff B. Wilson Professor of Economics at the University of California–Berkeley, will discuss “The Macroeconomic Policy Response to the Pandemic: The Good, the Bad and the Ugly” on Tuesday, March 9, beginning at 4 p.m. CT. Her virtual talk is the spring 2021 McGee Public Policy Lecture sponsored by the Department of Economics.
Despite limitations of pandemic, research continues in Basic Sciences, Engineering
Feb. 24, 2021—During the Research Ramp-up process, more than 3,000 Vanderbilt research personnel have returned to in-person research activities, while many others have continued remotely through perseverance and ingenuity. The efforts of the School of Medicine Basic Science's Danny Winder and the School ofEngineering's Ethan Lippmann are highlighted.
SARS-CoV-2 protein blocks an essential step in host gene expression, new discovery finds
Feb. 17, 2021—Vanderbilt biochemist Yi Ren is part of a team that has identified a new behavior of a SARS-CoV-2 protein and discovered that interfering with its function can block virus replication in host cells. This opens up the potential for new therapeutic targets for COVID-19.
Pulling Through: For alumni working in VUMC’s COVID-19 unit, the pandemic has offered lessons in heartbreak and resiliency
Feb. 16, 2021—In January 2020, the accelerating spread of SARS-CoV-2 made it apparent that VUMC’s two-bed Contagious Disease Response Unit, created for the rare victim of Ebola or other more-isolated emerging pathogen, would not suffice if Nashville were to be hit hard. So administrators began planning for a major outbreak.
Dr. Buddy Creech answers first-year students’ COVID-19 questions
Feb. 15, 2021—Vanderbilt first-year students recently met with Buddy Creech, director of the Vanderbilt Vaccine Research Program and associate professor of pediatrics, for a special virtual chat to answer some of their COVID-19 vaccine questions.
Vanderbilt Diabetes Center seeks pilot and feasibility proposals to study interaction of SARS-CoV-2, diabetes
Dec. 16, 2020—The Vanderbilt Diabetes Center, the NIH-funded Diabetes Research and Training Center, and the NIH-funded Center for Diabetes Translational Research seek pilot and feasibility proposals to study the interaction of SARS-CoV-2/COVID-19 and diabetes.
Coronavirus expert Mark Denison shares COVID-19 research and insights
Dec. 16, 2020—One of the world’s foremost experts on coronaviruses, Dr. Mark R. Denison, shared his research and insights into COVID-19 during a webinar on Dec. 14. A video of the webinar is now available for viewing.